Suicide prevention strategies revisited: 10-year systematic review

Summary Background Many countries are developing suicide prevention strategies for which up-to-date, high-quality evidence is required. We present updated evidence for the effectiveness of suicide prevention interventions since 2005. Methods We searched PubMed and the Cochrane Library using multiple...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet. Psychiatry 2016-07, Vol.3 (7), p.646-659
Hauptverfasser: Zalsman, Gil, MD, Hawton, Keith, FMedSci, Wasserman, Danuta, MD, van Heeringen, Kees, MD, Arensman, Ella, PhD, Sarchiapone, Marco, MD, Carli, Vladimir, MD, Höschl, Cyril, MD, Barzilay, Ran, MD, Balazs, Judit, MD, Purebl, György, MD, Kahn, Jean Pierre, MD, Sáiz, Pilar Alejandra, MD, Lipsicas, Cendrine Bursztein, PhD, Bobes, Julio, MD, Cozman, Doina, MD, Hegerl, Ulrich, PhD, Zohar, Joseph, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 659
container_issue 7
container_start_page 646
container_title The Lancet. Psychiatry
container_volume 3
creator Zalsman, Gil, MD
Hawton, Keith, FMedSci
Wasserman, Danuta, MD
van Heeringen, Kees, MD
Arensman, Ella, PhD
Sarchiapone, Marco, MD
Carli, Vladimir, MD
Höschl, Cyril, MD
Barzilay, Ran, MD
Balazs, Judit, MD
Purebl, György, MD
Kahn, Jean Pierre, MD
Sáiz, Pilar Alejandra, MD
Lipsicas, Cendrine Bursztein, PhD
Bobes, Julio, MD
Cozman, Doina, MD
Hegerl, Ulrich, PhD
Zohar, Joseph, MD
description Summary Background Many countries are developing suicide prevention strategies for which up-to-date, high-quality evidence is required. We present updated evidence for the effectiveness of suicide prevention interventions since 2005. Methods We searched PubMed and the Cochrane Library using multiple terms related to suicide prevention for studies published between Jan 1, 2005, and Dec 31, 2014. We assessed seven interventions: public and physician education, media strategies, screening, restricting access to suicide means, treatments, and internet or hotline support. Data were extracted on primary outcomes of interest, namely suicidal behaviour (suicide, attempt, or ideation), and intermediate or secondary outcomes (treatment-seeking, identification of at-risk individuals, antidepressant prescription or use rates, or referrals). 18 suicide prevention experts from 13 European countries reviewed all articles and rated the strength of evidence using the Oxford criteria. Because the heterogeneity of populations and methodology did not permit formal meta-analysis, we present a narrative analysis. Findings We identified 1797 studies, including 23 systematic reviews, 12 meta-analyses, 40 randomised controlled trials (RCTs), 67 cohort trials, and 22 ecological or population-based investigations. Evidence for restricting access to lethal means in prevention of suicide has strengthened since 2005, especially with regard to control of analgesics (overall decrease of 43% since 2005) and hot-spots for suicide by jumping (reduction of 86% since 2005, 79% to 91%). School-based awareness programmes have been shown to reduce suicide attempts (odds ratio [OR] 0·45, 95% CI 0·24–0·85; p=0·014) and suicidal ideation (0·5, 0·27–0·92; p=0·025). The anti-suicidal effects of clozapine and lithium have been substantiated, but might be less specific than previously thought. Effective pharmacological and psychological treatments of depression are important in prevention. Insufficient evidence exists to assess the possible benefits for suicide prevention of screening in primary care, in general public education and media guidelines. Other approaches that need further investigation include gatekeeper training, education of physicians, and internet and helpline support. The paucity of RCTs is a major limitation in the evaluation of preventive interventions. Interpretation In the quest for effective suicide prevention initiatives, no single strategy clearly stands above the others. Combi
doi_str_mv 10.1016/S2215-0366(16)30030-X
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_504566</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S221503661630030X</els_id><sourcerecordid>1801862872</sourcerecordid><originalsourceid>FETCH-LOGICAL-c510t-3dccb1e561def3908e4f8185bdcc64918ade52fb8a3c729352c04dc512afd6c63</originalsourceid><addsrcrecordid>eNqFkE9v1DAQxS0EolXpRwDlWA6BsR07Xg4gqPgnVeJQkPZmOfYEuc0mi8eh2m-Pd7PsgQsnj9-890b6MfacwysOXL--FYKrGqTWV1y_lAAS6vUjdn6U2-bxadb6jF0S3QEAlw2otnnKzkQrzEqCPGcfbufoY8Bqm_A3jjlOY0U5uYw_I1JVxEgxY3hTcah36FJFO8q4cTn6wxYfnrEnvRsIL4_vBfvx6eP36y_1zbfPX6_f39Recci1DN53HJXmAXu5AoNNb7hRXdF1s-LGBVSi74yTvhUrqYSHJpSscH3QXssLVi-99IDbubPbFDcu7ezkoj1K92VCq6BReu-_WvzbNP2akbLdRPI4DG7EaSbLDXCjhWlFsarF6tNElLA_lXOwe-L2QNzucdryOxC365J7cTwxdxsMp9RfvsXwbjFgAVNgJUs-4ugxxIQ-2zDF_554-0-DH-IYvRvucYd0N81pLNQttyQsLCX7Dq4PDWv5Byu-pbs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1801862872</pqid></control><display><type>article</type><title>Suicide prevention strategies revisited: 10-year systematic review</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Zalsman, Gil, MD ; Hawton, Keith, FMedSci ; Wasserman, Danuta, MD ; van Heeringen, Kees, MD ; Arensman, Ella, PhD ; Sarchiapone, Marco, MD ; Carli, Vladimir, MD ; Höschl, Cyril, MD ; Barzilay, Ran, MD ; Balazs, Judit, MD ; Purebl, György, MD ; Kahn, Jean Pierre, MD ; Sáiz, Pilar Alejandra, MD ; Lipsicas, Cendrine Bursztein, PhD ; Bobes, Julio, MD ; Cozman, Doina, MD ; Hegerl, Ulrich, PhD ; Zohar, Joseph, MD</creator><creatorcontrib>Zalsman, Gil, MD ; Hawton, Keith, FMedSci ; Wasserman, Danuta, MD ; van Heeringen, Kees, MD ; Arensman, Ella, PhD ; Sarchiapone, Marco, MD ; Carli, Vladimir, MD ; Höschl, Cyril, MD ; Barzilay, Ran, MD ; Balazs, Judit, MD ; Purebl, György, MD ; Kahn, Jean Pierre, MD ; Sáiz, Pilar Alejandra, MD ; Lipsicas, Cendrine Bursztein, PhD ; Bobes, Julio, MD ; Cozman, Doina, MD ; Hegerl, Ulrich, PhD ; Zohar, Joseph, MD</creatorcontrib><description>Summary Background Many countries are developing suicide prevention strategies for which up-to-date, high-quality evidence is required. We present updated evidence for the effectiveness of suicide prevention interventions since 2005. Methods We searched PubMed and the Cochrane Library using multiple terms related to suicide prevention for studies published between Jan 1, 2005, and Dec 31, 2014. We assessed seven interventions: public and physician education, media strategies, screening, restricting access to suicide means, treatments, and internet or hotline support. Data were extracted on primary outcomes of interest, namely suicidal behaviour (suicide, attempt, or ideation), and intermediate or secondary outcomes (treatment-seeking, identification of at-risk individuals, antidepressant prescription or use rates, or referrals). 18 suicide prevention experts from 13 European countries reviewed all articles and rated the strength of evidence using the Oxford criteria. Because the heterogeneity of populations and methodology did not permit formal meta-analysis, we present a narrative analysis. Findings We identified 1797 studies, including 23 systematic reviews, 12 meta-analyses, 40 randomised controlled trials (RCTs), 67 cohort trials, and 22 ecological or population-based investigations. Evidence for restricting access to lethal means in prevention of suicide has strengthened since 2005, especially with regard to control of analgesics (overall decrease of 43% since 2005) and hot-spots for suicide by jumping (reduction of 86% since 2005, 79% to 91%). School-based awareness programmes have been shown to reduce suicide attempts (odds ratio [OR] 0·45, 95% CI 0·24–0·85; p=0·014) and suicidal ideation (0·5, 0·27–0·92; p=0·025). The anti-suicidal effects of clozapine and lithium have been substantiated, but might be less specific than previously thought. Effective pharmacological and psychological treatments of depression are important in prevention. Insufficient evidence exists to assess the possible benefits for suicide prevention of screening in primary care, in general public education and media guidelines. Other approaches that need further investigation include gatekeeper training, education of physicians, and internet and helpline support. The paucity of RCTs is a major limitation in the evaluation of preventive interventions. Interpretation In the quest for effective suicide prevention initiatives, no single strategy clearly stands above the others. Combinations of evidence-based strategies at the individual level and the population level should be assessed with robust research designs. Funding The Expert Platform on Mental Health, Focus on Depression, and the European College of Neuropsychopharmacology.</description><identifier>ISSN: 2215-0366</identifier><identifier>ISSN: 2215-0374</identifier><identifier>EISSN: 2215-0374</identifier><identifier>DOI: 10.1016/S2215-0366(16)30030-X</identifier><identifier>PMID: 27289303</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Humans ; Program Evaluation ; Psychiatry ; Randomized Controlled Trials as Topic ; Suicide - prevention &amp; control</subject><ispartof>The Lancet. Psychiatry, 2016-07, Vol.3 (7), p.646-659</ispartof><rights>Elsevier Ltd</rights><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c510t-3dccb1e561def3908e4f8185bdcc64918ade52fb8a3c729352c04dc512afd6c63</citedby><cites>FETCH-LOGICAL-c510t-3dccb1e561def3908e4f8185bdcc64918ade52fb8a3c729352c04dc512afd6c63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27289303$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:134140001$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Zalsman, Gil, MD</creatorcontrib><creatorcontrib>Hawton, Keith, FMedSci</creatorcontrib><creatorcontrib>Wasserman, Danuta, MD</creatorcontrib><creatorcontrib>van Heeringen, Kees, MD</creatorcontrib><creatorcontrib>Arensman, Ella, PhD</creatorcontrib><creatorcontrib>Sarchiapone, Marco, MD</creatorcontrib><creatorcontrib>Carli, Vladimir, MD</creatorcontrib><creatorcontrib>Höschl, Cyril, MD</creatorcontrib><creatorcontrib>Barzilay, Ran, MD</creatorcontrib><creatorcontrib>Balazs, Judit, MD</creatorcontrib><creatorcontrib>Purebl, György, MD</creatorcontrib><creatorcontrib>Kahn, Jean Pierre, MD</creatorcontrib><creatorcontrib>Sáiz, Pilar Alejandra, MD</creatorcontrib><creatorcontrib>Lipsicas, Cendrine Bursztein, PhD</creatorcontrib><creatorcontrib>Bobes, Julio, MD</creatorcontrib><creatorcontrib>Cozman, Doina, MD</creatorcontrib><creatorcontrib>Hegerl, Ulrich, PhD</creatorcontrib><creatorcontrib>Zohar, Joseph, MD</creatorcontrib><title>Suicide prevention strategies revisited: 10-year systematic review</title><title>The Lancet. Psychiatry</title><addtitle>Lancet Psychiatry</addtitle><description>Summary Background Many countries are developing suicide prevention strategies for which up-to-date, high-quality evidence is required. We present updated evidence for the effectiveness of suicide prevention interventions since 2005. Methods We searched PubMed and the Cochrane Library using multiple terms related to suicide prevention for studies published between Jan 1, 2005, and Dec 31, 2014. We assessed seven interventions: public and physician education, media strategies, screening, restricting access to suicide means, treatments, and internet or hotline support. Data were extracted on primary outcomes of interest, namely suicidal behaviour (suicide, attempt, or ideation), and intermediate or secondary outcomes (treatment-seeking, identification of at-risk individuals, antidepressant prescription or use rates, or referrals). 18 suicide prevention experts from 13 European countries reviewed all articles and rated the strength of evidence using the Oxford criteria. Because the heterogeneity of populations and methodology did not permit formal meta-analysis, we present a narrative analysis. Findings We identified 1797 studies, including 23 systematic reviews, 12 meta-analyses, 40 randomised controlled trials (RCTs), 67 cohort trials, and 22 ecological or population-based investigations. Evidence for restricting access to lethal means in prevention of suicide has strengthened since 2005, especially with regard to control of analgesics (overall decrease of 43% since 2005) and hot-spots for suicide by jumping (reduction of 86% since 2005, 79% to 91%). School-based awareness programmes have been shown to reduce suicide attempts (odds ratio [OR] 0·45, 95% CI 0·24–0·85; p=0·014) and suicidal ideation (0·5, 0·27–0·92; p=0·025). The anti-suicidal effects of clozapine and lithium have been substantiated, but might be less specific than previously thought. Effective pharmacological and psychological treatments of depression are important in prevention. Insufficient evidence exists to assess the possible benefits for suicide prevention of screening in primary care, in general public education and media guidelines. Other approaches that need further investigation include gatekeeper training, education of physicians, and internet and helpline support. The paucity of RCTs is a major limitation in the evaluation of preventive interventions. Interpretation In the quest for effective suicide prevention initiatives, no single strategy clearly stands above the others. Combinations of evidence-based strategies at the individual level and the population level should be assessed with robust research designs. Funding The Expert Platform on Mental Health, Focus on Depression, and the European College of Neuropsychopharmacology.</description><subject>Humans</subject><subject>Program Evaluation</subject><subject>Psychiatry</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Suicide - prevention &amp; control</subject><issn>2215-0366</issn><issn>2215-0374</issn><issn>2215-0374</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE9v1DAQxS0EolXpRwDlWA6BsR07Xg4gqPgnVeJQkPZmOfYEuc0mi8eh2m-Pd7PsgQsnj9-890b6MfacwysOXL--FYKrGqTWV1y_lAAS6vUjdn6U2-bxadb6jF0S3QEAlw2otnnKzkQrzEqCPGcfbufoY8Bqm_A3jjlOY0U5uYw_I1JVxEgxY3hTcah36FJFO8q4cTn6wxYfnrEnvRsIL4_vBfvx6eP36y_1zbfPX6_f39Recci1DN53HJXmAXu5AoNNb7hRXdF1s-LGBVSi74yTvhUrqYSHJpSscH3QXssLVi-99IDbubPbFDcu7ezkoj1K92VCq6BReu-_WvzbNP2akbLdRPI4DG7EaSbLDXCjhWlFsarF6tNElLA_lXOwe-L2QNzucdryOxC365J7cTwxdxsMp9RfvsXwbjFgAVNgJUs-4ugxxIQ-2zDF_554-0-DH-IYvRvucYd0N81pLNQttyQsLCX7Dq4PDWv5Byu-pbs</recordid><startdate>20160701</startdate><enddate>20160701</enddate><creator>Zalsman, Gil, MD</creator><creator>Hawton, Keith, FMedSci</creator><creator>Wasserman, Danuta, MD</creator><creator>van Heeringen, Kees, MD</creator><creator>Arensman, Ella, PhD</creator><creator>Sarchiapone, Marco, MD</creator><creator>Carli, Vladimir, MD</creator><creator>Höschl, Cyril, MD</creator><creator>Barzilay, Ran, MD</creator><creator>Balazs, Judit, MD</creator><creator>Purebl, György, MD</creator><creator>Kahn, Jean Pierre, MD</creator><creator>Sáiz, Pilar Alejandra, MD</creator><creator>Lipsicas, Cendrine Bursztein, PhD</creator><creator>Bobes, Julio, MD</creator><creator>Cozman, Doina, MD</creator><creator>Hegerl, Ulrich, PhD</creator><creator>Zohar, Joseph, MD</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>20160701</creationdate><title>Suicide prevention strategies revisited: 10-year systematic review</title><author>Zalsman, Gil, MD ; Hawton, Keith, FMedSci ; Wasserman, Danuta, MD ; van Heeringen, Kees, MD ; Arensman, Ella, PhD ; Sarchiapone, Marco, MD ; Carli, Vladimir, MD ; Höschl, Cyril, MD ; Barzilay, Ran, MD ; Balazs, Judit, MD ; Purebl, György, MD ; Kahn, Jean Pierre, MD ; Sáiz, Pilar Alejandra, MD ; Lipsicas, Cendrine Bursztein, PhD ; Bobes, Julio, MD ; Cozman, Doina, MD ; Hegerl, Ulrich, PhD ; Zohar, Joseph, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c510t-3dccb1e561def3908e4f8185bdcc64918ade52fb8a3c729352c04dc512afd6c63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Humans</topic><topic>Program Evaluation</topic><topic>Psychiatry</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Suicide - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zalsman, Gil, MD</creatorcontrib><creatorcontrib>Hawton, Keith, FMedSci</creatorcontrib><creatorcontrib>Wasserman, Danuta, MD</creatorcontrib><creatorcontrib>van Heeringen, Kees, MD</creatorcontrib><creatorcontrib>Arensman, Ella, PhD</creatorcontrib><creatorcontrib>Sarchiapone, Marco, MD</creatorcontrib><creatorcontrib>Carli, Vladimir, MD</creatorcontrib><creatorcontrib>Höschl, Cyril, MD</creatorcontrib><creatorcontrib>Barzilay, Ran, MD</creatorcontrib><creatorcontrib>Balazs, Judit, MD</creatorcontrib><creatorcontrib>Purebl, György, MD</creatorcontrib><creatorcontrib>Kahn, Jean Pierre, MD</creatorcontrib><creatorcontrib>Sáiz, Pilar Alejandra, MD</creatorcontrib><creatorcontrib>Lipsicas, Cendrine Bursztein, PhD</creatorcontrib><creatorcontrib>Bobes, Julio, MD</creatorcontrib><creatorcontrib>Cozman, Doina, MD</creatorcontrib><creatorcontrib>Hegerl, Ulrich, PhD</creatorcontrib><creatorcontrib>Zohar, Joseph, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>The Lancet. Psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zalsman, Gil, MD</au><au>Hawton, Keith, FMedSci</au><au>Wasserman, Danuta, MD</au><au>van Heeringen, Kees, MD</au><au>Arensman, Ella, PhD</au><au>Sarchiapone, Marco, MD</au><au>Carli, Vladimir, MD</au><au>Höschl, Cyril, MD</au><au>Barzilay, Ran, MD</au><au>Balazs, Judit, MD</au><au>Purebl, György, MD</au><au>Kahn, Jean Pierre, MD</au><au>Sáiz, Pilar Alejandra, MD</au><au>Lipsicas, Cendrine Bursztein, PhD</au><au>Bobes, Julio, MD</au><au>Cozman, Doina, MD</au><au>Hegerl, Ulrich, PhD</au><au>Zohar, Joseph, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suicide prevention strategies revisited: 10-year systematic review</atitle><jtitle>The Lancet. Psychiatry</jtitle><addtitle>Lancet Psychiatry</addtitle><date>2016-07-01</date><risdate>2016</risdate><volume>3</volume><issue>7</issue><spage>646</spage><epage>659</epage><pages>646-659</pages><issn>2215-0366</issn><issn>2215-0374</issn><eissn>2215-0374</eissn><abstract>Summary Background Many countries are developing suicide prevention strategies for which up-to-date, high-quality evidence is required. We present updated evidence for the effectiveness of suicide prevention interventions since 2005. Methods We searched PubMed and the Cochrane Library using multiple terms related to suicide prevention for studies published between Jan 1, 2005, and Dec 31, 2014. We assessed seven interventions: public and physician education, media strategies, screening, restricting access to suicide means, treatments, and internet or hotline support. Data were extracted on primary outcomes of interest, namely suicidal behaviour (suicide, attempt, or ideation), and intermediate or secondary outcomes (treatment-seeking, identification of at-risk individuals, antidepressant prescription or use rates, or referrals). 18 suicide prevention experts from 13 European countries reviewed all articles and rated the strength of evidence using the Oxford criteria. Because the heterogeneity of populations and methodology did not permit formal meta-analysis, we present a narrative analysis. Findings We identified 1797 studies, including 23 systematic reviews, 12 meta-analyses, 40 randomised controlled trials (RCTs), 67 cohort trials, and 22 ecological or population-based investigations. Evidence for restricting access to lethal means in prevention of suicide has strengthened since 2005, especially with regard to control of analgesics (overall decrease of 43% since 2005) and hot-spots for suicide by jumping (reduction of 86% since 2005, 79% to 91%). School-based awareness programmes have been shown to reduce suicide attempts (odds ratio [OR] 0·45, 95% CI 0·24–0·85; p=0·014) and suicidal ideation (0·5, 0·27–0·92; p=0·025). The anti-suicidal effects of clozapine and lithium have been substantiated, but might be less specific than previously thought. Effective pharmacological and psychological treatments of depression are important in prevention. Insufficient evidence exists to assess the possible benefits for suicide prevention of screening in primary care, in general public education and media guidelines. Other approaches that need further investigation include gatekeeper training, education of physicians, and internet and helpline support. The paucity of RCTs is a major limitation in the evaluation of preventive interventions. Interpretation In the quest for effective suicide prevention initiatives, no single strategy clearly stands above the others. Combinations of evidence-based strategies at the individual level and the population level should be assessed with robust research designs. Funding The Expert Platform on Mental Health, Focus on Depression, and the European College of Neuropsychopharmacology.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27289303</pmid><doi>10.1016/S2215-0366(16)30030-X</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2215-0366
ispartof The Lancet. Psychiatry, 2016-07, Vol.3 (7), p.646-659
issn 2215-0366
2215-0374
2215-0374
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_504566
source MEDLINE; Alma/SFX Local Collection
subjects Humans
Program Evaluation
Psychiatry
Randomized Controlled Trials as Topic
Suicide - prevention & control
title Suicide prevention strategies revisited: 10-year systematic review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T10%3A43%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suicide%20prevention%20strategies%20revisited:%2010-year%20systematic%20review&rft.jtitle=The%20Lancet.%20Psychiatry&rft.au=Zalsman,%20Gil,%20MD&rft.date=2016-07-01&rft.volume=3&rft.issue=7&rft.spage=646&rft.epage=659&rft.pages=646-659&rft.issn=2215-0366&rft.eissn=2215-0374&rft_id=info:doi/10.1016/S2215-0366(16)30030-X&rft_dat=%3Cproquest_swepu%3E1801862872%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1801862872&rft_id=info:pmid/27289303&rft_els_id=1_s2_0_S221503661630030X&rfr_iscdi=true